NASDAQ : ADAP

Adaptimmune Therapeutics plc

$0.0485 USD

$0.0 (-3.0%)

Volume
1.68M
Average Volume
110.64M
Market Capitalization
$75.16M
P/E Ratio
-0.16
Dividend Yield
0.00%
Price Target
$3.00
Year High
$0.86
Year Low
$0.02
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.52

ADAP Estimated and Actual Revenue by Quarter

ADAP Estimated and Actual EPS by Quarter

ADAP Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-30 1 -8.08M -8.08M -8.08M -8.19M -8.19M -8.19M
2026-09-30 1 -7.56M -7.56M -7.56M -7.67M -7.67M -7.67M
2026-06-30 1 -2.15M -2.15M -2.15M -2.18M -2.18M -2.18M
2026-03-30 1 -6.49M -6.49M -6.49M -6.58M -6.58M -6.58M
2025-12-30 2 -4.17M -4.17M -4.17M -4.23M -4.23M -4.23M
2025-09-30 2 -4.17M -4.17M -4.17M -4.23M -4.23M -4.23M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-30 1 -5.28M -5.28M -5.28M 46.76M 46.76M 46.76M
2026-09-30 1 -5.28M -5.28M -5.28M 43.78M 43.78M 43.78M
2026-06-30 1 -5.28M -5.28M -5.28M 12.44M 12.44M 12.44M
2026-03-30 1 -5.28M -5.28M -5.28M 37.56M 37.56M 37.56M
2025-12-30 2 -11.92M -1.99M -6.95M 24.13M 24.13M 24.13M
2025-09-30 2 -17.37M -7.24M -13.03M 24.13M 24.13M 24.13M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-30 1 9.4M 9.4M 9.4M 1 -0.02 -0.02 -0.02
2026-09-30 1 8.8M 8.8M 8.8M 1 -0.02 -0.02 -0.02
2026-06-30 1 2.5M 2.5M 2.5M 1 -0.02 -0.02 -0.02
2026-03-30 1 7.55M 7.55M 7.55M 1 -0.02 -0.02 -0.02
2025-12-30 2 4.85M 4.85M 4.85M 1 -0.04514229 -0.00752371 -0.026333
2025-09-30 2 4.85M 4.85M 4.85M 1 -0.06577733 -0.02740722 -0.049333